Goldman Sachs Aktienanleihe CEC 2.../ DE000GG8V0E7 /
| 2024-06-27 10:44:13 AM | Chg.-0.25 | Bid12:25:59 PM | Ask12:25:59 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 100.12EUR | -0.25% | 100.15 Bid Size: 30,000 |
101.65 Ask Size: 30,000 |
CECONOMY AG INH O.N... | 2.80 - | 2025-04-24 | Call |
GlobeNewswire
12:40 PM
Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER Wa...
GlobeNewswire
12:30 PM
X4 Pharmaceuticals Announces Positive Interim Clinical Data from Ongoing Six-Month Phase 2 Trial of ...
GlobeNewswire
12:30 PM
Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
GlobeNewswire
12:15 PM
H World Group Limited Announces Voting Results of 2024 Annual General Meeting
GlobeNewswire
12:00 PM
Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Inte...
GlobeNewswire
12:00 PM
Nightfood Holdings Inc. New Subsidiary, Future Hospitality Ventures, Solves Hospitality Labor Crisis
GlobeNewswire
12:00 PM
Action1 Achieves CSA STAR Level 1 Certification and Signs CISA's Secure by Design Pledge
GlobeNewswire
12:00 PM
Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Ann...
GlobeNewswire
12:00 PM
FUTUREFUEL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed A...
GlobeNewswire
12:00 PM
GenVivo Announces Initiation of Patient Dosing in a US Phase I/Ib Clinical Trial Evaluating GEN2, a ...
GlobeNewswire
12:00 PM
Interlock Launches ThreatSlayer Web3 Security Extension and Incentivized Crowdsourced Internet Secur...
GlobeNewswire
12:00 PM
LanzaTech and LanzaJet Introduce CirculAir™, a Revolutionary and Commercially Ready Solution to Conv...
GlobeNewswire
11:56 AM
Cost of new drug development is key concern for life science as focus shifts to repurposing
